Dixon Hubard Feinour & Brown’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-131
| Closed | -$50K | – | 214 |
|
|
2021
Q1 | $50K | Hold |
131
| – | – | 0.01% | 204 |
|
|
2020
Q4 | $50K | Hold |
131
| – | – | 0.01% | 179 |
|
|
2020
Q3 | $50K | Hold |
131
| – | – | 0.01% | 179 |
|
|
2020
Q2 | $59K | Hold |
131
| – | – | 0.02% | 183 |
|
|
2020
Q1 | $48K | Hold |
131
| – | – | 0.02% | 165 |
|
|
2019
Q4 | $93K | Hold |
131
| – | – | 0.02% | 179 |
|
|
2019
Q3 | $84K | Hold |
131
| – | – | 0.02% | 176 |
|
|
2019
Q2 | $115K | Hold |
131
| – | – | 0.03% | 177 |
|
|
2019
Q1 | $76K | Hold |
131
| – | – | 0.02% | 171 |
|
|
2018
Q4 | $37K | Hold |
131
| – | – | 0.01% | 162 |
|
|
2018
Q3 | $63K | Hold |
131
| – | – | 0.02% | 177 |
|
|
2018
Q2 | $59K | Hold |
131
| – | – | 0.02% | 165 |
|
|
2018
Q1 | $77K | Hold |
131
| – | – | 0.02% | 188 |
|
|
2017
Q4 | $81K | Sell |
131
-52
| -28% | -$32.2K | 0.02% | 188 |
|
|
2017
Q3 | $168K | Hold |
183
| – | – | 0.05% | 177 |
|
|
2017
Q2 | $170K | Hold |
183
| – | – | 0.05% | 176 |
|
|
2017
Q1 | $174K | Hold |
183
| – | – | 0.05% | 175 |
|
|
2016
Q4 | $147K | Hold |
183
| – | – | 0.05% | 167 |
|
|
2016
Q3 | $154K | Sell |
183
-33
| -15% | -$27.8K | 0.05% | 168 |
|
|
2016
Q2 | $178K | Hold |
216
| – | – | 0.06% | 164 |
|
|
2016
Q1 | $255K | Hold |
216
| – | – | 0.08% | 144 |
|
|
2015
Q4 | $269K | Buy |
216
+1
| +0.5% | +$1.25K | 0.09% | 140 |
|
|
2015
Q3 | $291K | Buy |
215
+106
| +97% | +$143K | 0.11% | 127 |
|
|
2015
Q2 | $197K | Buy |
+109
| New | +$197K | 0.06% | 178 |
|